MaxCyte Inc (MXCT) Ord USD0.01 (DI)
20.00p
(2.94%)
- Add to watchlist
- Create an alert
- This stock can be held in a
20.00p
(2.94%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
20.00p
(2.94%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
690.00p
700.00p
700.00p
£541.96 million
680.00p
665.00p
120.00p
n/a
10.00p (1.49%) Previous:
10.00p
64,268
n/a
750
Performance
| 1 week 1W | 11.11% | 1 year 1Y | 326.83% |
|---|---|---|---|
| 1 month 1M | 53.51% | 2 years 2Y | 278.38% |
| 3 months 3M | 70.73% | 3 years 3Y | 151.8% |
| 6 months 6M | 192.89% | 5 years 5Y | n/a |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
| Year ending: | 31/12/2019 | 31/12/2018 |
|---|---|---|
| Revenue ($m) | 21.62 | 16.67 |
| Profit before tax ($m) | (12.89) | (8.87) |
| Adjusted EPS (¢): | (23.00) | (17.00) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.
Ready to take your first step?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
There are no documents available for this stock.
Broker forecasts
Due to changes in how we source investment data, Broker Forecasts are not available. We're sorry for any inconvenience this may cause.
-
MaxCyte revenue growth expected to accelerate faster than anticipated
20 January 2021 10:05
-
MaxCyte appoints Amanda Murphy as CFO
9 September 2020 09:35
-
MaxCyte to consolidate stock to single trading line
21 February 2020 11:53
-
Increase to Block Listing
21 January 2021 14:49
-
Trading Update
20 January 2021 07:00
-
Myeloid Therapeutics Clinical & Commercial License
11 January 2021 07:00
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
Annual & interim reports
Annual & interim reports are not available for this stock.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.